.png)
.png)
Mark Giganti, PhD
Research Scientist
Harvard T.H. Chan School of Public Health
Boston, MA, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Kara W. Chew, M.D., M.S.
Associate Professor
David Geffen School of Medicine at University of California
Los Angeles, California, United States
Disclosure: Disclosure(s): Merck Sharp & Dohme: Grant/Research Support (); Pardes Bioscences: Advisor/Consultant ()
Joseph J. Eron, MD
Professor
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States
Disclosure: Disclosure(s): GSK: Advisor/Consultant (); Merck: Advisor/Consultant ()
Jonathan Z. Li, MD, MMSc
Associate Professor of Medicine
Brigham and Women's Hospital
Boston, MA, United States
Disclosure: Disclosure(s): Abbvie: Advisor/Consultant (); Merck: Grant/Research Support ()
Mauricio Pinilla, MS
Biostatistician
Harvard TH Chan School of Public Health
East Boston, Massachusetts, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Carlee Moser, Ph.D.
Senior Research Scientist
Harvard T.H. Chan School of Public Health
Boston, Massachusetts, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Arzhang Cyrus Javan, M.D., MPH, DTM&H
National Institutes of Health
Bethesda, Maryland, United States
Disclosure: Disclosure(s): No financial relationships to disclose
William A. Fischer, II, MD
Associate Professor of Medicine
Institute for Global Health and Infectious Diseases, the University of North Carolina
Chapel Hill, North Carolina, United States
Disclosure: Disclosure(s): Janssen: Adjudication Committee (Influenza) (); Merck: Advisor/Consultant (); Ridgeback Biopharmaceuticals: Research funding provided to the University of North Carolina (); Roche: Advisor/Consultant (); Syneos: Adjudication committee (Influenza) ()
Paul Klekotka, MD, PhD
Lilly Biotechnology Center
San Diego, California, United States
Disclosure: Disclosure(s): Eli Lilly: Employee (), Stocks/Bonds ()
David A. Margolis, MD MPH
Head of Infectious Diseases Therapy Area
Brii Biosciences
Durham, NC, United States
Disclosure: Disclosure(s): Brii Biosciences: Stocks/Bonds ()
David A. Wohl, M.D.
Professor
University of North Carolina at Chapel Hill School of Medicine
Chapel Hill, North Carolina, United States
Disclosure: Disclosure(s): Gilead: Advisor/Consultant (), Grant/Research Support (); Lilly: Grant/Research Support (); ViiV: Advisor/Consultant (), Grant/Research Support ()
Robert Coombs, M.D., Ph.D.
University of Washington
Seattle, Washington, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Eric S. Daar, M.D.
Chief, Division of HIV Medicine
Lundquist Institute at Harbor-UCLA Medical Center
Torrance, California, United States
Disclosure: Disclosure(s): Gilead: Advisor/Consultant (), Grant/Research Support (); Merck: Advisor/Consultant (); ViiV: Advisor/Consultant (), Grant/Research Support ()
Davey M. Smith, M.D., M.A.S.
Head (Division of ID & GPH), Professor & Vice-Chair of Research (Medicine), Co-Director (CFAR)
University of California, San Diego
La Jolla, California, United States
Disclosure: Disclosure(s): Arena Pharmaceuticals: Advisor/Consultant (); Bayer Pharmaceuticals: Advisor/Consultant (); Brio Clinical.: Advisor/Consultant (); Fluxergy: Advisor/Consultant (); Kiadis: Advisor/Consultant (); Linear Therapies: Advisor/Consultant (); Matrix BioMed: Advisor/Consultant (); Model Medicines: Advisor/Consultant (); Signant Health: Advisor/Consultant (); VxBiosciences: Advisor/Consultant ()
Michael D. Hughes, Ph.D.
Harvard T.H. Chan School of Public Health
Boston, Massachusetts, United States
Disclosure: Disclosure(s): No financial relationships to disclose
Judith S. Currier, M.D., MSc
Professor of Medicine/Chief, Division of ID
David Geffen School of Medicine at University of California
Los Angeles, California, United States
Disclosure: Disclosure(s): Merck: Advisor/Consultant ()